NGL Fine Chem

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE887E01022
  • NSEID: NGLFINE
  • BSEID: 524774
INR
1,823.55
73.55 (4.2%)
BSENSE

Feb 03

BSE+NSE Vol: 6.4 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Kwality Pharma
Venus Remedies
Fredun Pharma
Sakar Healthcare
NGL Fine Chem
Fermenta Biotec.
Syncom Formul.
Lincoln Pharma.
Ind-Swift Labs.
Jagsonpal Pharma
Bajaj Healthcare
Why is NGL Fine Chem Ltd ?
1
Poor long term growth as Operating profit has grown by an annual rate -5.13% of over the last 5 years
2
Flat results in Sep 25
  • PAT(9M) At Rs 19.41 cr has Grown at -38.09%
  • ROCE(HY) Lowest at 8.00%
  • DEBTORS TURNOVER RATIO(HY) Lowest at 3.63 times
3
With ROCE of 7.2, it has a Expensive valuation with a 2.6 Enterprise value to Capital Employed
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -28.64%, its profits have fallen by -50%
4
Despite the size of the company, domestic mutual funds hold only 0% of the company
  • Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business
5
Below par performance in long term as well as near term
  • Along with generating -28.64% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to NGL Fine Chem should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is NGL Fine Chem for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
NGL Fine Chem
15.41%
-0.54
52.57%
Sensex
8.49%
0.43
11.83%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
17.35%
EBIT Growth (5y)
-5.13%
EBIT to Interest (avg)
24.50
Debt to EBITDA (avg)
0.91
Net Debt to Equity (avg)
0.11
Sales to Capital Employed (avg)
1.22
Tax Ratio
23.77%
Dividend Payout Ratio
5.12%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
21.36%
ROE (avg)
16.28%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
52
Industry P/E
32
Price to Book Value
3.57
EV to EBIT
46.49
EV to EBITDA
27.94
EV to Capital Employed
3.32
EV to Sales
2.71
PEG Ratio
NA
Dividend Yield
0.10%
ROCE (Latest)
7.15%
ROE (Latest)
6.89%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

10What is working for the Company
OPERATING CF(Y)

Highest at Rs 35.82 Cr

NET SALES(Q)

Highest at Rs 120.26 cr

PBDIT(Q)

Highest at Rs 17.16 cr.

OPERATING PROFIT TO NET SALES(Q)

Highest at 14.27%

PBT LESS OI(Q)

At Rs 10.91 cr has Grown at 32.89%

-6What is not working for the Company
PAT(9M)

At Rs 19.41 cr has Grown at -38.09%

ROCE(HY)

Lowest at 8.00%

DEBTORS TURNOVER RATIO(HY)

Lowest at 3.63 times

Loading Valuation Snapshot...
Here's what is working for NGL Fine Chem
Operating Cash Flow - Annually
Highest at Rs 35.82 Cr
in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (Rs Cr)

Net Sales - Quarterly
Highest at Rs 120.26 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Net Sales - Quarterly
At Rs 120.26 cr has Grown at 28.65%
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 17.16 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Highest at 14.27%
in the last five quarters
MOJO Watch
Company's efficiency has improved

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 10.91 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 10.91 cr has Grown at 32.89%
Year on Year (YoY)
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Here's what is not working for NGL Fine Chem
Profit After Tax (PAT) - Nine Monthly
At Rs 19.41 cr has Grown at -38.09%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is negative

PAT (Rs Cr)

Debtors Turnover Ratio- Half Yearly
Lowest at 3.63 times
in the last five half yearly periods
MOJO Watch
Company's pace of settling its Debtors has slowed

Debtors Turnover Ratio